Why We Can’t Stop Arguing About S.S.R.I.s
Sep 16, 2026 · 42m
More News podcasts
Summary
This episode of The Opinions features David Ross, Rachel Bedard, and Dr. Anthony Rostain discussing the widespread use of SSRIs and the current political debate surrounding psychiatric medication. The guests examine the evolution of these drugs, the shift from the "chemical imbalance" theory to neuroplasticity, and the challenges of safely tapering off medications. They argue that while SSRIs are useful tools, they are often misused or prescribed without adequate access to therapy and social support.
Topics discussed
Sponsor: Instacart and its new AI assistant Clementine
Introduction: The debate on psychiatric drugs and therapy access
RFK Jr.'s initiative to reduce psychiatric drug use in children
Doctor's perspective: Prescribing meds due to lack of therapy access
History of SSRIs: Safety improvements over previous drugs
Efficacy and the shift from chemical imbalance to neuroplasticity
Neuroplasticity: How meds help rewire brain circuits
Patient fears about brain changes and identity
The necessity of medication for severe pain and suffering
Population-level effectiveness and the insulin analogy
Treatment-resistant depression and unknown biological mechanisms
The brain as a 'black box' and patient autonomy
Why therapy is often more effective than medication alone
Accessibility barriers: Pills vs. variable therapy quality
The need for allies in mental health: Teachers and parents
Social determinants: Loneliness and environmental causes
Assessing if a patient is ready for therapeutic work
Navigating the combative discourse around de-prescribing
Misuse of stimulants and SSRIs without evidence
Addressing misuse and the need for $1B in therapy access
Building meaningful structures and reducing stigma
Sponsor: NY Times subscription offer
Criticism that the MAHA report was overdue
The gap between best practice and real-world prescribing
Long-term use: Short trials vs. lifelong medication needs
Patient choice to stay on medication if it is working
Assessing readiness to taper off medication
Chronic conditions and individualized tapering plans
Discontinuation syndrome and genetic factors in withdrawal
Case study: Extremely slow tapering to avoid panic
Over-medication of children: A serious but complex question
Parental decision-making: Balancing risks and benefits
Listening to the child's experience and side effects
Common side effects: Blunting, sleep issues, and fogginess
The black box warning and its impact on pediatric prescribing
Distinguishing withdrawal symptoms from returning illness
Managing diagnostic uncertainty during tapering
Rising diagnosis rates vs. increased access and reduced taboo
Societal factors: Pandemic, economy, and atomization
Stigma and shame as risk factors for seeking help
Holistic approach: Meds, therapy, and lifestyle changes
The importance of social support and healthy lifestyle
Humanism in medicine: Solving problems beyond pills
Starting points: Schools, workplaces, and family support
Demystifying mental health education for families
Sponsor: Yale New Haven Health
More from The Opinions
Listen ad-free on Castria